Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer.
PSMA
genitourinary
molecular imaging
oncology
positron emission imaging
prostate cancer
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
10 05 2021
10 05 2021
Historique:
received:
19
01
2021
accepted:
01
03
2021
pubmed:
14
3
2021
medline:
27
8
2021
entrez:
13
3
2021
Statut:
ppublish
Résumé
Prostate-specific membrane antigen (PSMA) is highly expressed on most prostate cancer (PCa) cells, and several PSMA ligands for PET imaging are now available worldwide.
Identifiants
pubmed: 33712536
pii: jnumed.120.257238
doi: 10.2967/jnumed.120.257238
doi:
Substances chimiques
Antigens, Surface
0
FOLH1 protein, human
EC 3.4.17.21
Glutamate Carboxypeptidase II
EC 3.4.17.21
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
596-604Informations de copyright
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.